Boryung signs deal with Stendhal to launch hypertension drug in Mexico

The S.Korean drug maker aims to increase the market share of Kanarb in Mexico and enter the public insurance market

Boryung signs deal with Stendhal to launch hypertension drug in Mexico
Ji-Hyun Lee 1
2023-02-27 17:10:41 bluesky@hankyung.com
Bio & Pharma

Boryung, a South Korean pharmaceutical company, said on Monday it had signed a deal with Stendhal SA de CV, a Mexican medical specialty company, to launch its hypertension combination drug Dukarb Plus in Mexico this year.

Dukarb Plus is part of Boryung’s Kanarb Family product line, which consists of Kanarb, a new hypertension drug, and its combination drugs Kanarb Plus that add other hypertension treatment ingredients. Dukarb Plus combines Kanarb with a calcium channel blocker and a diuretic.

Boryung said it aimed to increase the market share of the Kanarb Family in Mexico and enter the public insurance market with Stendhal’s support.

The company also said it had presented the clinical effects and prescription cases of Kanarb products at the International Conference on Cardiovascular Intervention (CADECI) held in Mexico on Feb. 23.

“We will continue to strengthen cooperation with Stendhal and increase our market share in Mexico through expanding Kanarb’s lineup,” Boryung CEO Daniel Chang said in a statement.

Write to Ji-Hyun Lee at bluesky@hankyung.com
##Boryung Stendhal SA Dukarb Kanarb #korea boryung stendhal #boryung mexico kanarb #boryung dukarb plus mexico

Dongwon solo bidder for Boryung Biopharma estimated at $385 mn

Dongwon solo bidder for Boryung Biopharma estimated at $385 mn

Boryung Biopharma's typhoid vaccine Zerotyph (Courtesy of Boryung Biopharma) South Korea’s leading seafood and logistics conglomerate Dongwon Group is seeking to buy local biopharmaceutical company Boryung Biopharma Co. as part of its efforts to find a new growth engine.The seafood giant&

S.Korea's Boryung receives EU GMP certification

S.Korea's Boryung receives EU GMP certification

Boryung's Yesan campus  South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, has received European Union GMP certification. The facility underwent review by the German government's drug licensing

Boryung holds Care-in-Space Challenge in US for space healthcare startups

Boryung holds Care-in-Space Challenge in US for space healthcare startups

 NASA's last space shuttle Endeavor on display at the 1st Care-in-Space event  South Korea's pharmaceutical company Boryeong said on Friday that it held the first "Care-in-Space Challenge" event, a new space healthcare startup fostering program, in Los Angeles on Tuesday.The CIS Chall

Boryung takes 'health is wealth' to whole new level – space

Boryung takes 'health is wealth' to whole new level – space

The 11-person crew aboard the ISS (Courtesy of NASA) South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharmaceutical, is one of them. The pharmaceutical giant announced Tuesday that it will host an ac
(* comment hide *}